NCT02700399

Brief Summary

The purpose of this study is to determine if the pulse pressure changes are different whether patients are training in a traditional tilt table as compared to a robotic assisted tilt table, which induces leg movement.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
13

participants targeted

Target at below P25 for not_applicable

Timeline
Completed

Started Jul 2015

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

July 1, 2015

Completed
7 months until next milestone

First Submitted

Initial submission to the registry

February 5, 2016

Completed
1 month until next milestone

First Posted

Study publicly available on registry

March 7, 2016

Completed
25 days until next milestone

Primary Completion

Last participant's last visit for primary outcome

April 1, 2016

Completed
2 months until next milestone

Study Completion

Last participant's last visit for all outcomes

June 1, 2016

Completed
Last Updated

June 28, 2016

Status Verified

June 1, 2016

Enrollment Period

9 months

First QC Date

February 5, 2016

Last Update Submit

June 27, 2016

Conditions

Keywords

Rehabilitation

Outcome Measures

Primary Outcomes (1)

  • Change in Non Invasive Blood Pressure(NIBP)

    Measured at: Baseline in supine on tilttable, 60 seconds after 30 degrees rise of tilttable, 60 seconds after 60 degrees tilt is reached. Again 60 seconds after return to 0 degrees tilt with patient still in supine position on tilttable..

Secondary Outcomes (1)

  • Patient reported comfort: The difference in prevalence of both acceptable- and not acceptable patient comfort between the Erigo and the conventional tilt-table.

    Question is asked within 5 minutes after 60 degrees NIBP measurement

Study Arms (2)

Erigo® First

OTHER

Erigo® 0 - 60 degrees - Wash out period (min 30 minutes, max 120 minutes) - Traditional Tilt table 0 - 60 degrees Step frequency on Erigo® = 48

Device: Erigo® HocomaDevice: Traditional tilt table from Rehab-Care

Traditional first

OTHER

Traditional Tilt table 0 - 60 degrees - Wash out period (min 30 minutes, max 120 minutes) - Erigo® 0 - 60 degrees Step frequency on Erigo® = 48

Device: Erigo® HocomaDevice: Traditional tilt table from Rehab-Care

Interventions

Robotics assisted tilt table, without functional electrical stimulation

Erigo® FirstTraditional first

Traditional tilt table

Erigo® FirstTraditional first

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Already being treated with traditional tilttable and must be able to benefit from Erigo® treatment from a clinicians view
  • Acquired brain injury as primary diagnose

You may not qualify if:

  • Not on mechanical ventilation
  • New cerebral, cardiological or other medical problems/emergencies between the 2 interventions
  • Change in cardiac medications between interventions
  • Patient must not have independent gait function immediately before trial
  • must not have EFA(Early Functional abilities) part score \> 4 in the section "Standing", assessed by the treating physiotherapist.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Regionshospitalet Hammel Neurocenter

Hammel, 8450, Denmark

Location

MeSH Terms

Conditions

Brain InjuriesHypotension, OrthostaticSyncope

Condition Hierarchy (Ancestors)

Brain DiseasesCentral Nervous System DiseasesNervous System DiseasesCraniocerebral TraumaTrauma, Nervous SystemWounds and InjuriesOrthostatic IntolerancePrimary DysautonomiasAutonomic Nervous System DiseasesHypotensionVascular DiseasesCardiovascular DiseasesUnconsciousnessConsciousness DisordersNeurobehavioral ManifestationsNeurologic ManifestationsSigns and SymptomsPathological Conditions, Signs and Symptoms

Study Officials

  • Jørgen F Nielsen, Prof.MD DMSc

    Regionshospitalet Hammel Neurocenter

    STUDY DIRECTOR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
NONE
Purpose
TREATMENT
Intervention Model
CROSSOVER
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

February 5, 2016

First Posted

March 7, 2016

Study Start

July 1, 2015

Primary Completion

April 1, 2016

Study Completion

June 1, 2016

Last Updated

June 28, 2016

Record last verified: 2016-06

Data Sharing

IPD Sharing
Will not share

Locations